Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence

Abstract Objective(s) This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence. Study design We utilized a bioinformatics-based strategy to screen for candidate genes and fibroblast g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of obstetrics & gynecology and reproductive biology 2015-01, Vol.184, p.117-124
Hauptverfasser: Zhao, Linjie, Yang, Huiliang, Xuan, Yu, Luo, Zhongyue, Lin, Qiao, Zhao, Jitong, Ren, Ning, Zhou, Shengtao, Zhao, Xia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124
container_issue
container_start_page 117
container_title European journal of obstetrics & gynecology and reproductive biology
container_volume 184
creator Zhao, Linjie
Yang, Huiliang
Xuan, Yu
Luo, Zhongyue
Lin, Qiao
Zhao, Jitong
Ren, Ning
Zhou, Shengtao
Zhao, Xia
description Abstract Objective(s) This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence. Study design We utilized a bioinformatics-based strategy to screen for candidate genes and fibroblast growth factor receptor 1(FGFR1) was chosen for further validation. FGFR1 expression was examined in specimens of ectopic and eutopic endometrium obtained from 48 patients with endometriosis and specimens of eutopic endometrium from 26 healthy control subjects using immunohistochemistry and Western blotting. In addition, FGFR shRNA treatment was applied in a nude mice endometriosis model to examine the functional role of FGFR1 in endometriosis formation in vivo. Results FGFR1 was found commonly overexpressed in ectopic endometrium of endometriosis compared with either its eutopic counterpart or endometrium from normal patients ( P < 0.05). FGFR shRNA treatment impaired endometriosis formation and alleviated endometriosis-related symptoms in vivo . FGFR1 expression in ectopic endometrium was correlated with dysmenorrhea severity ( P < 0.05) and recurrence in endometriosis patients ( P < 0.05). Conclusion(s) FGFR1 might be involved in endometriosis development, which could possibly serve as a novel therapeutic target and prognostic marker for this disease.
doi_str_mv 10.1016/j.ejogrb.2014.11.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1642608330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S030121151400596X</els_id><sourcerecordid>1642608330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-bc61951b43b76e0c40d8c8f8fc41b85030c637508badc6542bb82de70a5a07843</originalsourceid><addsrcrecordid>eNqFUk1v1TAQtBAVfRT-AUI-cknwxnGSd0FCFdBKlTi0lbhZ_ti0Don9sJOW90v4u3X6ChJc8MWWdmZ2PbOEvAFWAoPm_VDiEG6iLisGdQlQMuDPyAa6tiraRtTPyYZxBkUFII7Jy5QGlg_n2xfkuBKCMcHFhvw69yaiSmgp_txFTMkFT0NPe6dj0KNKM72J4X6-pb0yc4g0osHd-gDqPEVvw4RzdCG5RJW31M2JmhAjjmpete5d5v4FKx5ruaPdpwl9xt6ieuRm7SUzvcFX5KhXY8LXT_cJuf786er0rLj4-uX89ONFYWpo50KbBrYCdM112yAzNbOd6fquz2XdiWyAaXgrWKeVNdmUSuuustgyJRRru5qfkHcH3V0MPxZMs5xcMjiOymNYkoSmrhrWcc4ytD5ATQwpRezlLrpJxb0EJtdI5CAPkcg1EgkgcySZ9vapw6IntH9IvzPIgA8HAOZ_3jmMMhm3emBd9mOWNrj_dfhXwIzOO6PG77jHNIQl-uyhBJkqyeTluhbrVkCdB9g23_gD0CS3oQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1642608330</pqid></control><display><type>article</type><title>Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhao, Linjie ; Yang, Huiliang ; Xuan, Yu ; Luo, Zhongyue ; Lin, Qiao ; Zhao, Jitong ; Ren, Ning ; Zhou, Shengtao ; Zhao, Xia</creator><creatorcontrib>Zhao, Linjie ; Yang, Huiliang ; Xuan, Yu ; Luo, Zhongyue ; Lin, Qiao ; Zhao, Jitong ; Ren, Ning ; Zhou, Shengtao ; Zhao, Xia</creatorcontrib><description>Abstract Objective(s) This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence. Study design We utilized a bioinformatics-based strategy to screen for candidate genes and fibroblast growth factor receptor 1(FGFR1) was chosen for further validation. FGFR1 expression was examined in specimens of ectopic and eutopic endometrium obtained from 48 patients with endometriosis and specimens of eutopic endometrium from 26 healthy control subjects using immunohistochemistry and Western blotting. In addition, FGFR shRNA treatment was applied in a nude mice endometriosis model to examine the functional role of FGFR1 in endometriosis formation in vivo. Results FGFR1 was found commonly overexpressed in ectopic endometrium of endometriosis compared with either its eutopic counterpart or endometrium from normal patients ( P &lt; 0.05). FGFR shRNA treatment impaired endometriosis formation and alleviated endometriosis-related symptoms in vivo . FGFR1 expression in ectopic endometrium was correlated with dysmenorrhea severity ( P &lt; 0.05) and recurrence in endometriosis patients ( P &lt; 0.05). Conclusion(s) FGFR1 might be involved in endometriosis development, which could possibly serve as a novel therapeutic target and prognostic marker for this disease.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2014.11.013</identifier><identifier>PMID: 25500535</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Animals ; Computational Biology ; Disease Models, Animal ; Dysmenorrhea ; Dysmenorrhea - etiology ; Dysmenorrhea - genetics ; Dysmenorrhea - metabolism ; Dysmenorrhea - pathology ; Endometriosis ; Endometriosis - complications ; Endometriosis - genetics ; Endometriosis - metabolism ; Endometriosis - pathology ; Endometrium - metabolism ; Endometrium - pathology ; Female ; FGFR1 ; Gene Expression Profiling ; Humans ; Mice ; Mice, Nude ; Obstetrics and Gynecology ; Receptor, Fibroblast Growth Factor, Type 1 - genetics ; Receptor, Fibroblast Growth Factor, Type 1 - metabolism ; Recurrence</subject><ispartof>European journal of obstetrics &amp; gynecology and reproductive biology, 2015-01, Vol.184, p.117-124</ispartof><rights>2014</rights><rights>Copyright © 2014. Published by Elsevier Ireland Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-bc61951b43b76e0c40d8c8f8fc41b85030c637508badc6542bb82de70a5a07843</citedby><cites>FETCH-LOGICAL-c417t-bc61951b43b76e0c40d8c8f8fc41b85030c637508badc6542bb82de70a5a07843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S030121151400596X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25500535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Linjie</creatorcontrib><creatorcontrib>Yang, Huiliang</creatorcontrib><creatorcontrib>Xuan, Yu</creatorcontrib><creatorcontrib>Luo, Zhongyue</creatorcontrib><creatorcontrib>Lin, Qiao</creatorcontrib><creatorcontrib>Zhao, Jitong</creatorcontrib><creatorcontrib>Ren, Ning</creatorcontrib><creatorcontrib>Zhou, Shengtao</creatorcontrib><creatorcontrib>Zhao, Xia</creatorcontrib><title>Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence</title><title>European journal of obstetrics &amp; gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>Abstract Objective(s) This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence. Study design We utilized a bioinformatics-based strategy to screen for candidate genes and fibroblast growth factor receptor 1(FGFR1) was chosen for further validation. FGFR1 expression was examined in specimens of ectopic and eutopic endometrium obtained from 48 patients with endometriosis and specimens of eutopic endometrium from 26 healthy control subjects using immunohistochemistry and Western blotting. In addition, FGFR shRNA treatment was applied in a nude mice endometriosis model to examine the functional role of FGFR1 in endometriosis formation in vivo. Results FGFR1 was found commonly overexpressed in ectopic endometrium of endometriosis compared with either its eutopic counterpart or endometrium from normal patients ( P &lt; 0.05). FGFR shRNA treatment impaired endometriosis formation and alleviated endometriosis-related symptoms in vivo . FGFR1 expression in ectopic endometrium was correlated with dysmenorrhea severity ( P &lt; 0.05) and recurrence in endometriosis patients ( P &lt; 0.05). Conclusion(s) FGFR1 might be involved in endometriosis development, which could possibly serve as a novel therapeutic target and prognostic marker for this disease.</description><subject>Animals</subject><subject>Computational Biology</subject><subject>Disease Models, Animal</subject><subject>Dysmenorrhea</subject><subject>Dysmenorrhea - etiology</subject><subject>Dysmenorrhea - genetics</subject><subject>Dysmenorrhea - metabolism</subject><subject>Dysmenorrhea - pathology</subject><subject>Endometriosis</subject><subject>Endometriosis - complications</subject><subject>Endometriosis - genetics</subject><subject>Endometriosis - metabolism</subject><subject>Endometriosis - pathology</subject><subject>Endometrium - metabolism</subject><subject>Endometrium - pathology</subject><subject>Female</subject><subject>FGFR1</subject><subject>Gene Expression Profiling</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Obstetrics and Gynecology</subject><subject>Receptor, Fibroblast Growth Factor, Type 1 - genetics</subject><subject>Receptor, Fibroblast Growth Factor, Type 1 - metabolism</subject><subject>Recurrence</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk1v1TAQtBAVfRT-AUI-cknwxnGSd0FCFdBKlTi0lbhZ_ti0Don9sJOW90v4u3X6ChJc8MWWdmZ2PbOEvAFWAoPm_VDiEG6iLisGdQlQMuDPyAa6tiraRtTPyYZxBkUFII7Jy5QGlg_n2xfkuBKCMcHFhvw69yaiSmgp_txFTMkFT0NPe6dj0KNKM72J4X6-pb0yc4g0osHd-gDqPEVvw4RzdCG5RJW31M2JmhAjjmpete5d5v4FKx5ruaPdpwl9xt6ieuRm7SUzvcFX5KhXY8LXT_cJuf786er0rLj4-uX89ONFYWpo50KbBrYCdM112yAzNbOd6fquz2XdiWyAaXgrWKeVNdmUSuuustgyJRRru5qfkHcH3V0MPxZMs5xcMjiOymNYkoSmrhrWcc4ytD5ATQwpRezlLrpJxb0EJtdI5CAPkcg1EgkgcySZ9vapw6IntH9IvzPIgA8HAOZ_3jmMMhm3emBd9mOWNrj_dfhXwIzOO6PG77jHNIQl-uyhBJkqyeTluhbrVkCdB9g23_gD0CS3oQ</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Zhao, Linjie</creator><creator>Yang, Huiliang</creator><creator>Xuan, Yu</creator><creator>Luo, Zhongyue</creator><creator>Lin, Qiao</creator><creator>Zhao, Jitong</creator><creator>Ren, Ning</creator><creator>Zhou, Shengtao</creator><creator>Zhao, Xia</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence</title><author>Zhao, Linjie ; Yang, Huiliang ; Xuan, Yu ; Luo, Zhongyue ; Lin, Qiao ; Zhao, Jitong ; Ren, Ning ; Zhou, Shengtao ; Zhao, Xia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-bc61951b43b76e0c40d8c8f8fc41b85030c637508badc6542bb82de70a5a07843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Computational Biology</topic><topic>Disease Models, Animal</topic><topic>Dysmenorrhea</topic><topic>Dysmenorrhea - etiology</topic><topic>Dysmenorrhea - genetics</topic><topic>Dysmenorrhea - metabolism</topic><topic>Dysmenorrhea - pathology</topic><topic>Endometriosis</topic><topic>Endometriosis - complications</topic><topic>Endometriosis - genetics</topic><topic>Endometriosis - metabolism</topic><topic>Endometriosis - pathology</topic><topic>Endometrium - metabolism</topic><topic>Endometrium - pathology</topic><topic>Female</topic><topic>FGFR1</topic><topic>Gene Expression Profiling</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Obstetrics and Gynecology</topic><topic>Receptor, Fibroblast Growth Factor, Type 1 - genetics</topic><topic>Receptor, Fibroblast Growth Factor, Type 1 - metabolism</topic><topic>Recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Linjie</creatorcontrib><creatorcontrib>Yang, Huiliang</creatorcontrib><creatorcontrib>Xuan, Yu</creatorcontrib><creatorcontrib>Luo, Zhongyue</creatorcontrib><creatorcontrib>Lin, Qiao</creatorcontrib><creatorcontrib>Zhao, Jitong</creatorcontrib><creatorcontrib>Ren, Ning</creatorcontrib><creatorcontrib>Zhou, Shengtao</creatorcontrib><creatorcontrib>Zhao, Xia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Linjie</au><au>Yang, Huiliang</au><au>Xuan, Yu</au><au>Luo, Zhongyue</au><au>Lin, Qiao</au><au>Zhao, Jitong</au><au>Ren, Ning</au><au>Zhou, Shengtao</au><au>Zhao, Xia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence</atitle><jtitle>European journal of obstetrics &amp; gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>184</volume><spage>117</spage><epage>124</epage><pages>117-124</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>Abstract Objective(s) This study aims to identify a critical molecule that potentially participates in endometriosis pathogenesis and characterize its correlation with dysmenorrhea and recurrence. Study design We utilized a bioinformatics-based strategy to screen for candidate genes and fibroblast growth factor receptor 1(FGFR1) was chosen for further validation. FGFR1 expression was examined in specimens of ectopic and eutopic endometrium obtained from 48 patients with endometriosis and specimens of eutopic endometrium from 26 healthy control subjects using immunohistochemistry and Western blotting. In addition, FGFR shRNA treatment was applied in a nude mice endometriosis model to examine the functional role of FGFR1 in endometriosis formation in vivo. Results FGFR1 was found commonly overexpressed in ectopic endometrium of endometriosis compared with either its eutopic counterpart or endometrium from normal patients ( P &lt; 0.05). FGFR shRNA treatment impaired endometriosis formation and alleviated endometriosis-related symptoms in vivo . FGFR1 expression in ectopic endometrium was correlated with dysmenorrhea severity ( P &lt; 0.05) and recurrence in endometriosis patients ( P &lt; 0.05). Conclusion(s) FGFR1 might be involved in endometriosis development, which could possibly serve as a novel therapeutic target and prognostic marker for this disease.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25500535</pmid><doi>10.1016/j.ejogrb.2014.11.013</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-2115
ispartof European journal of obstetrics & gynecology and reproductive biology, 2015-01, Vol.184, p.117-124
issn 0301-2115
1872-7654
language eng
recordid cdi_proquest_miscellaneous_1642608330
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Computational Biology
Disease Models, Animal
Dysmenorrhea
Dysmenorrhea - etiology
Dysmenorrhea - genetics
Dysmenorrhea - metabolism
Dysmenorrhea - pathology
Endometriosis
Endometriosis - complications
Endometriosis - genetics
Endometriosis - metabolism
Endometriosis - pathology
Endometrium - metabolism
Endometrium - pathology
Female
FGFR1
Gene Expression Profiling
Humans
Mice
Mice, Nude
Obstetrics and Gynecology
Receptor, Fibroblast Growth Factor, Type 1 - genetics
Receptor, Fibroblast Growth Factor, Type 1 - metabolism
Recurrence
title Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A01%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20expression%20of%20fibroblast%20growth%20factor%20receptor%201%20in%20endometriosis%20and%20its%20correlation%20with%20endometriosis-related%20dysmenorrhea%20and%20recurrence&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Zhao,%20Linjie&rft.date=2015-01-01&rft.volume=184&rft.spage=117&rft.epage=124&rft.pages=117-124&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2014.11.013&rft_dat=%3Cproquest_cross%3E1642608330%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1642608330&rft_id=info:pmid/25500535&rft_els_id=1_s2_0_S030121151400596X&rfr_iscdi=true